Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia
EDMONTON, AB , Feb. 20, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the company's extended pastille offerings in Australia . This expansion marks another meaningful step in Aurora's deep commitment to offering patients a diverse range of high-quality, premium medical cannabis products to meet their various needs and interests.
"Expanding our portfolio of medical cannabis pastilles in Australia demonstrates our understanding of market demand and is another example of our ability to bring high quality product to this key market as patient interest increases," said Andre Jerome , Executive Vice President of Global Business Development at Aurora. "In this rapidly expanding market, we're leveraging our unique capabilities, including global manufacturing and excellence in navigating regulatory frameworks that define Aurora's leadership."
Medical cannabis pastilles offer several key benefits, including easy oral intake. The prolonged effects provide long-lasting and extended relief after digestion. Pastilles also come in an accessible format that is discrete, portable, and convenient.
The pastilles that are now available in Australia include:
Aurora Pastilles - 10mg THC Pomegranate Berry (30 pack)
Aurora Pastilles - 10:10 Balanced Pineapple (30 pack)
Aurora Pastilles - 25mg CBD Acai Berry (30 pack)
Aurora maintains its position as the largest global medical cannabis company operating in nationally legal markets. The company has a robust innovation pipeline planned for global introduction over the course of the coming months, bringing variety and new options to patients.
About Aurora Cannabis Inc.
Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada , Europe , Australia and New Zealand . Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Information:
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law (" forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's expanded pastilles offerings in the Australian market, including the associated benefits to the Company, as well as the benefits to the pastille format for patients, and statements regarding expectations for the continued rapid expansion of the Australian market, the Company's upcoming innovation pipeline, and position as the largest medical global cannabis company operating in nationally legal markets.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 20, 2024 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
15 minutes ago
- CBC
Changing supply one reason for declining opioid deaths, analysis shows
A new report from the Canadian Centre on Substance Use and Addiction points to changes in the drug supply and the reality that many vulnerable users have already died as reasons for a decline in opioid toxicity deaths in Canada from 2023 to 2024.
Cision Canada
an hour ago
- Cision Canada
Montreal's Airwaves Were Filled with Hope Today Français
MONTRÉAL, Aug. 21, 2025 /CNW/ - The halls of The Montreal Children's Hospital (The Children's) were filled with emotion today as courageous and resilient families took to the airwaves to share their stories during the 22 nd annual Caring for Kids Radiothon. Live from the P.K. Subban Atrium, Bell Media 's radio stations— CJAD 800, 95.9 Virgin Radio, CHOM 97 7, and TSN Radio 690, along with CTV News, who joined forces to bring listeners deeply moving stories from families whose lives have been forever changed by the exceptional care at The Children's. The day culminated in a heartwarming moment when nine-year-old Zack, who lives with cerebral palsy, stepped up to the mic and announced the final fundraising total: an incredible $1,402,011 raised by the Quebec community to help sick children and teens get back to what they do best—being kids. As we like to say: A bratty kid is a healthy kid —and today, thanks to the kindness of our donors, more children like Zack are getting back on their feet, raising a little ruckus, and rediscovering the joys of childhood. Real Impact. Real Lives Changed. Since its launch in 2004, the Caring for Kids Radiothon has raised more than $32.5 million for The Montreal Children's Hospital Foundation, delivering life-saving care and much-needed comfort to sick children, teens, and expectant mothers facing high-risk pregnancies across Quebec. In the past year alone, donor support has helped: The Pavillion Kat Demes: A second home for out-of-town families with a child who is hospitalized for an extended period of time; The only dedicated Child Life team in Quebec, which through games and creative activities spanning music therapy and pet therapy, helps to improve the quality of life at the Hospital; The Birthing Centre, thanks to the purchase of JADA balloons, an innovative technology which treats post-partum hemorrhaging in just one hour, allowing new mothers to get home to their child more quickly. "This event is a powerful reminder of what compassion can achieve," said Renée Vézina, President of The Montreal Children's Hospital Foundation. "Every gift helps bring comfort, healing, and brighter tomorrows to children facing serious illness. And when those kids are well enough to run, yell, and make a little mischief—we know we're doing something right—because a bratty kid is a healthy kid. And that's exactly what we want." Donors Make a Huge Difference Proceeds from the Radiothon support the Healthy Kids Fund, which provides The Children's with the financial means to act quickly when unexpected challenges arise—whether it's replacing essential equipment, launching urgent services, or offering specialized training. The fund ensures sick children receive timely, high-quality care without interruption. Thank You to Our Sponsors This year's Radiothon was also a success thanks to the incredible generosity of our sponsors, whose commitment to children's health ensures that every child, teen, and expectant mother with a high-risk pregnancy receives specialized care, comfort, and hope. Thank you to: Dormez-vous – Phone Bank Partner The Tenaquip Foundation – Caring Together Sponsor AtkinsRéalis, CN, Fuel Transport, Goldwater Droit, Otsuka Canada Pharmaceuticals Inc. and Rio Tinto – Our Miracle Hour Sponsors Senville – Miracle Break Sponsor And a huge thank you to our long-standing broadcast partner and champion of our cause Bell Media and its media organizations CJAD 800, 95.9 Virgin Radio, CHOM 97 7, TSN Radio 690, and CTV News Montreal for their unwavering support. ABOUT THE MONTREAL CHILDREN'S HOSPITAL FOUNDATION (THE CHILDREN'S FOUNDATION) The mission of The Children's Foundation is to inspire and mobilize the community to support innovation in clinical care, research and teaching in pediatric and maternal-fetal care at The Montreal Children's Hospital (The Children's), the pediatric teaching hospital of McGill's Faculty of Medicine and Health Sciences, and the Child Health and Human Development Program (CCHD) of the Research Institute of the McGill University Health Centre, one of Canada's top three research centres. Our major fundraising initiative, the Unexpected Ways to Heal campaign, aims to raise $200 million by 2026. Funds raised will advance groundbreaking projects in pediatric and maternal-fetal care that will push the envelope on an international scale and help The Children's to find Unexpected Ways to Heal. Since its founding in 1973, the Foundation has raised over $750 million, which has helped sick children from across Quebec and around the world to get back on their feet and return to their mischievous ways. Because a bratty kid is a healthy kid. Please visit for more information.
Globe and Mail
2 hours ago
- Globe and Mail
Newegg Announces First Half 2025 Results
Newegg Commerce, Inc. (NASDAQ: NEGG) (the 'Company' or 'Newegg'), a leading global technology e-commerce retailer, today announced results for the six months ended June 30, 2025. 'Newegg experienced strong year-over-year growth in the first half of 2025, driven primarily by increased demand for GPUs and other core PC components, including the highly successful launch of the NVIDIA GeForce RTX 50 Series and AMD Radeon RX 9000 Series graphics cards, and AMD Ryzen 9000X3D Series CPUs,' said Newegg Chief Executive Officer Anthony Chow. 'These new product launches further boosted organic traffic and spurred robust cross-category purchasing, driving both topline growth and improved gross margins. We also benefited from pull-forward spending due to tariff uncertainty while simultaneously minimizing tariff impact on supply chain and customer experience through close collaboration with our key partners and suppliers. I am pleased with our results, and we will continue to be agile and opportunistic throughout the remainder of the year as we aim to deliver a superior experience for our loyal Newegg customers.' Newegg Interim Chief Financial Officer Christina Ching added, 'In the first half of 2025, Newegg demonstrated significant growth driven by robust sales of PC components, particularly boosted by positive momentum from the new GPU and CPU product launches. This strong consumer demand led to a 14% year-over-year increase in GMV and a 13% rise in net sales. Along with SG&A expense reductions following various strategic cost optimization measures throughout 2024 and 2025, our adjusted EBITDA improved substantially to $11.3 million for the six months ended June 30, 2025, up from a $7.3 million loss for the same period in 2024. We have also maintained focus on our cash balance and working capital. We also recently launched an 'at the market' (ATM) offering program, which we intend to use for general corporate purposes and working capital. As we move forward, our focus remains on maximizing market opportunities while navigating the ongoing tariff environment and other macroeconomic factors.' 2025 First Half Financial Highlights Net sales increased 12.6% to $695.7 million for the six months ended June 30, 2025, compared to $618.1 million for the six months ended June 30, 2024. GMV (defined below) increased 13.7% to $849.1 million for the six months ended June 30, 2025, compared to $746.7 million for the six months ended June 30, 2024. Gross profit increased 26.5% to $79.8 million for the six months ended June 30, 2025, compared to $63.1 million for the six months ended June 30, 2024. Net loss was $4.2 million for the six months ended June 30, 2025, compared to $25.0 million for the six months ended June 30, 2024. Adjusted EBITDA (defined below) was $11.3 million for the six months ended June 30, 2025, an increase of $18.6 million, compared to negative $7.3 million for the six months ended June 30, 2024. 2025 First Half Operational Metrics Average order value was $467 for the six months ended June 30, 2025, compared to $401 for same period in the prior year. Active customers, defined as unique customer IDs with at least one item purchased on Newegg platforms in the past six months, totaled approximately 1.13 million as of June 30, 2025, compared to 1.09 million for the same period in the prior year. Repeat purchase rate, which is the percentage of active customers who made at least two purchases on Newegg platforms during the past six months, was 25.2% as of June 30, 2025, compared to 23.0% for the same period in the prior year. Mr. Chow added, 'We are excited for several launches in the second half, including the expansion of our ABS line of PCs to high-performance workstations and tower servers, powered by industry-leading NVIDIA RTX PRO 6000 Blackwell graphic cards, helping businesses to explore and advance generative, agentic and physical AI. We will also be debuting our Gamer Community and Gamer Zone, which underscore our commitment to growing and supporting the gaming ecosystem, giving back to the very community that has fueled our success. We remain energized by our momentum, steadfast in optimizing our supply chain strategies to minimize any macroeconomic impacts, and confident in what lies ahead. ' About Newegg Newegg Commerce, Inc. (NASDAQ: NEGG), founded in 2001 and based in Diamond Bar, California, near Los Angeles, is a leading global online retailer for PC hardware, consumer electronics, gaming peripherals, home appliances, automotive and lifestyle technology. Newegg also serves businesses' e-commerce needs with marketing, supply chain, and technical solutions in a single platform. For more information, please visit Follow Newegg on X, TikTok, Instagram, Facebook, YouTube, Twitch, and Discord. Non-GAAP Financial Information This press release presents certain 'non-GAAP' financial measures. The components of these non-GAAP measures are computed by using amounts that are determined in accordance with accounting principles generally accepted in the United States of America ('GAAP'). A reconciliation of non-GAAP financial measures used in this press release to their nearest comparable GAAP financial measures is included in the schedules attached hereto. GMV The Company defines gross merchandise value, or GMV, as the total dollar value of products sold on its websites and third-party marketplace platforms, directly to customers and by its Marketplace sellers through Newegg Marketplace, net of returns, discounts, taxes, and cancellations. GMV also includes the services fees charged through its Newegg Partner Services in rendering services for its third-party logistics, shipped-by-Newegg, and media ad services, as well as the sales made by its Asia subsidiaries. Newegg believes that GMV helps it assess and analyze changes in revenues, and if reviewed in conjunction with net sales and other GAAP financial measures, can provide more information in evaluating its current performance and in assessing its future performance. Adjusted EBITDA Newegg calculates Adjusted EBITDA as net income/loss, excluding stock-based compensation expense, interest income, net, income tax (benefit) provision, depreciation and amortization expense, gain/loss from sales of fixed assets, gain/loss from sales of investment, and gain/loss from warrants liabilities. Newegg believes that exclusion of certain expenses in calculating Adjusted EBITDA facilitates operating performance comparisons on a period-to-period basis and excludes items that it does not consider to be indicative of its core operating performance. Accordingly, Newegg believes that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating its operating results in the same manner as its management and board of directors. Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of Newegg's results as reported under GAAP. Some of these limitations are: although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements; Adjusted EBITDA does not reflect changes in, or cash requirements for, working capital needs; Adjusted EBITDA does not consider the potentially dilutive impact of stock-based compensation; Adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to Newegg; and other companies, including companies in our industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure. Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including various cash flow metrics, operating profit and Newegg's other GAAP results. Cautionary Statement Concerning Forward-Looking Statements This news release includes 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements give our current expectations, opinions, beliefs or forecasts of future events and performance. A statement identified by the use of forward-looking words including 'will,' 'may,' 'expects,' 'projects,' 'plans,' 'believes,' 'should,' 'continue,' 'intend,' 'aim' and certain other statements about the future may be deemed forward-looking statements, including those regarding potential new product launches, the ability of new product launches to meet consumer needs, the Company's ability to navigate ongoing tariff uncertainty. Although Newegg believes that the expectations reflected in such forward-looking statements are reasonable at the time given, these statements involve risks and uncertainties that may cause actual future activities and results to be materially different from those suggested or described in this news release. These risks and uncertainties include changes in global economic and geopolitical conditions, fluctuations in customer demand and spending, inflation, interest rates and global supply chain constraints. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements in this press release are made as of the date hereof. The Company takes no obligation to update or correct its own forward-looking statements, except as required by law, or those prepared by third parties that are not paid for by the Company. The Company's SEC filings are available at June 30, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 59,063 $ 96,255 Restricted cash 843 3,487 Accounts receivable, net 28,970 64,363 Inventories, net 152,859 98,537 Income taxes receivable 2,085 2,452 Prepaid expenses 11,440 14,222 Other current assets 4,559 4,329 Total current assets 259,819 283,645 Property and equipment, net 46,597 51,175 Noncurrent deferred tax assets 915 914 Right of use assets, net 54,474 60,636 Other noncurrent assets 10,932 10,951 Total assets $ 372,737 $ 407,321 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 118,031 $ 148,279 Accrued liabilities 37,192 48,629 Deferred revenue 23,619 26,988 Line of credit 15,775 7,069 Lease liabilities – current 12,815 12,608 Total current liabilities 207,432 243,573 Income taxes payable 1,795 1,871 Lease liabilities – noncurrent 46,864 53,318 Other liabilities 2,545 2,467 Total liabilities 258,636 301,229 Stockholders' Equity Common Stock, $0.43696 par value; unlimited shares authorized; 19,499 and 19,478 shares issued and outstanding as of June 30, 2025, and December 31, 2024, respectively 8,521 8,512 Additional paid-in capital 300,628 289,096 Notes receivable – related party (15,187 ) (15,189 ) Accumulated other comprehensive loss (1,653 ) (2,300 ) Accumulated deficit (178,208 ) (174,027 ) Total stockholders' equity 114,101 106,092 Total liabilities and stockholders' equity $ 372,737 $ 407,321 NEWEGG COMMERCE, INC. Consolidated Statements of Operations (In thousands) (Unaudited) Six Months Ended June 30, 2025 2024 Net sales $ 695,670 $ 618,119 Cost of sales 615,878 555,003 Gross profit 79,792 63,116 Selling, general, and administrative expenses 87,329 93,083 Loss from operations (7,537 ) (29,967 ) Interest income 1,058 1,544 Interest expense (466 ) (440 ) Other income, net 3,410 1,880 Gain from sales of investment - 1,619 Change in fair value of warrants liabilities (72 ) (64 ) Loss before provision for (benefit from) income taxes (3,607 ) (25,428 ) Provision for (benefit from) income taxes 574 (474 ) Net loss $ (4,181 ) $ (24,954 ) NEWEGG COMMERCE, INC. Consolidated Statements of Cash Flows (In thousands) (Unaudited) Six Months Ended June 30, 2025 2024 Cash flows from operating activities: Net loss $ (4,181 ) $ (24,954 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 4,425 5,739 Allowance for expected credit losses 20 1,193 Allowance for related party receivables 2 - Provision for obsolete and excess inventory 1,359 1,569 Stock-based compensation 11,630 15,022 Gain from sales of investment - (1,619 ) Change in fair value of warrant liabilities 72 65 Loss (gain) on disposal of property and equipment (643 ) 52 Unrealized gain on marketable securities - (10 ) Deferred income taxes - (169 ) Changes in operating assets and liabilities: Accounts receivable 35,377 42,426 Inventories (55,168 ) 2,223 Prepaid expenses 2,807 4,913 Other assets 6,533 8,959 Accounts payable (30,604 ) (95,388 ) Accrued liabilities and other liabilities (18,099 ) (15,036 ) Deferred revenue (3,482 ) (8,182 ) Net cash used in operating activities (49,952 ) (63,197 ) Cash flows from investing activities: Payments to acquire property and equipment (1,248 ) (1,212 ) Proceeds on disposal of property and equipment 2,723 15 Proceeds from sale of investment - 2,076 Net cash provided by investing activities 1,475 879 Cash flows from financing activities: Borrowings under line of credit 10,000 41,098 Repayments under line of credit (1,751 ) (27,474 ) Repayments of long-term debt - (132 ) Proceeds from exercise of stock options - 95 Payments for employee taxes related to stock compensation (89 ) (241 ) Payments for shares buyback - (3,503 ) Net cash provided by financing activities 8,160 9,843 Foreign currency effect on cash, cash equivalents and restricted cash 481 (886 ) Net decrease in cash, cash equivalents and restricted cash (39,836 ) (53,361 ) Cash, cash equivalents and restricted cash: Beginning of period 99,742 106,474 End of period $ 59,906 $ 53,113 Schedule 1 Reconciliation of Net Sales to GMV (In millions) (Unaudited) Six Months Ended June 30, 2025 2024 Net Sales $ 695.7 $ 618.1 Adjustments: GMV - Marketplace 173.0 153.0 Marketplace Commission (14.3 ) (12.7 ) Deferred Revenue (4.6 ) (5.8 ) Other (0.7 ) (5.9 ) GMV $ 849.1 $ 746.7 Schedule 2 Reconciliation of Net Loss to Adjusted EBITDA (In millions) (Unaudited) Six Months Ended June 30, 2025 2024 Net loss $ (4.2 ) $ (25.0 ) Adjustments: Stock-based compensation expenses 11.6 15.0 Interest income, net (0.6 ) (1.1 ) Income tax (benefit) provision 0.6 (0.4 ) Depreciation and amortization 4.4 5.7 Gain from sale of fixed assets (0.6 ) - Gain from sale of investment - (1.6 ) Loss from change in fair value of warrants liabilities 0.1 0.1 Adjusted EBITDA $ 11.3 $ (7.3 )
